+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A prospective evaluation assessing the effectiveness of the 'Dynamax' mandibular appliance in the management of obstructive sleep apnoea

A prospective evaluation assessing the effectiveness of the 'Dynamax' mandibular appliance in the management of obstructive sleep apnoea

Surgeon 7(1): 14-17

Obstructive sleep apnoea syndrome (OSAS) affects 4-6% of the middle-aged UK population and is responsible for significant partnership disharmony. Nasal CPAP therapy is effective but has poor compliance in less severe cases- bulky with poor portability and frequently deemed socially unacceptable. The 'Dynamax mandibular appliance (DMA) is a current treatment for Skeletal 11 malocclusion characterised by mandibular retrusion. It has the advantage of both maxillary expansion and mandibular advancement and is developed and tailored on an individual basis by orthodontic sculpture. These facilities are widely available in hospital-based orthodontic departments. For these reasons we have explored its use in the treatment of mild to moderate cases of OSAS. 35 symptomatic patients (29 males) with mild to moderate OSAS, determined from sleep study analysis, had dental impressions taken and the 'Dynamax' appliance constructed. Following fitting and instructions for use, all patients were entered into the study. After two months, repeat overnight oximetry was undertaken for 16 patients and both an Epworth sleep score (ESS) and quality of life questionnaire completed. The mean age was 51 (range 29-71) years. The mean ESS pre-treatment was 12 (range 7-19) with a significant fall post-treatment by 7 (range 3-14) (p < 0.0001). Pre-treatment oximetry data confirmed typical tracings and patterns of OSAS with a mean low oxygen saturation (SaO2) of 83% (range 71-90%). Post-treatment oximetry was available in 16 patients and showed significant improvement in the number of hourly SaO2 desaturation dips and a mean increase of 4.7% in the lowest SaO2 recorded (p < 0.0001). Thirty (86%) patients found the appliance of 'great to moderate' benefit and 18 (60%) were able to tolerate it and be fully compliant within days. Of 10 patients who had previously experienced CPAP, 80% of them felt it was easier to tolerate the DA. Sixty-seven percent of these patients stated the appliance was more portable and acceptable to their bed partner. Twenty-one (70%) of bed partners reported softer and less frequent snoring. Ninety percent of the patients in this study wished to wear the DMA long-term. The DMA provides a satisfactory alternative therapy in the treatment of OSAS of'mild-moderate' severity. This oral device is conveniently small, readily portable and well tolerated by both patients and bed partners alike. It can be fashioned in orthodontic departments available in all district general hospitals and will enhance the provision and development of any local sleep service.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 051220996

Download citation: RISBibTeXText

PMID: 19241980

DOI: 10.1016/s1479-666x(09)80061-9

Related references

The treatment of severe obstructive sleep apnoea with mandibular advancement appliance. Annals of the Academy of Medicine Singapore 40(2): 108-110, 2011

Effects on blood pressure after treatment of obstructive sleep apnoea with a mandibular advancement appliance - a three-year follow-up. Journal of Oral Rehabilitation 36(10): 719-725, 2009

Mandibular advancement oral appliance therapy for obstructive sleep apnoea: Effect on awake calibre of the velopharynx. Thorax 54(11): 972-977, 1999

Mandibular advancement appliance for obstructive sleep apnoea: results of a randomised placebo controlled trial using parallel group design. Journal of Sleep Research 17(2): 221-229, 2008

A prospective randomized study of a dental appliance compared with uvulopalatopharyngoplasty in the treatment of obstructive sleep apnoea. Acta Oto-Laryngologica 119(4): 503-509, 1999

Nasopharyngoscopic evaluation of oral appliance therapy for obstructive sleep apnoea. European Respiratory Journal 35(4): 836-842, 2010

Endoscopy evaluation to predict oral appliance outcomes in obstructive sleep apnoea. European Respiratory Journal 47(5): 1410-1419, 2016

A systematic review of the efficacy of oral appliance design in the management of obstructive sleep apnoea. European Journal of Orthodontics 33(3): 318-324, 2011

A simple appliance for the management of obstructive sleep apnoea--the MEDUNSA Anti-Snoring Device (MASD). Sadj 59(4): 151-153, 2004

A combination appliance for obstructive sleep apnea: the effectiveness of mandibular advancement and tongue retention. Journal of Clinical Sleep Medicine 8(3): 265-269, 2012

Quality of life assessment of treatment with dental appliance or UPPP in patients with mild to moderate obstructive sleep apnoea. A prospective randomized 1-year follow-up study. Journal of Sleep Research 9(3): 303-308, 2000

Effective three-dimensional evaluation analysis of upper airway form during oral appliance therapy in patients with obstructive sleep apnoea. Journal of Oral Rehabilitation 40(8): 582-589, 2013

A prospective randomized study comparing two different degrees of mandibular advancement with a dental appliance in treatment of severe obstructive sleep apnea. Sleep and Breathing 7(3): 119-130, 2003